University OF Texas/texas AM Investment Management Co., 10% Owner at Aileron Therapeutics, Inc. (ALRN), sold 24,671 shares at $3.25 ($81K) on 2024-06-12, disclosed to the SEC on 2024-06-12.
Open-market sale of $81k ALRN by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.30 | 9,577 | $32K | 39.2% |
| 2 | $3.25 | 5,250 | $17K | 21.1% |
| 3 | $3.35 | 502 | $2K | 2.1% |
| 4 | $3.25 | 9,341 | $30K | 37.6% |
| 5 | $3.28 | 1 | $3 | 0.0% |
| Total | $3.27 avg | 24,671 |
| Ticker | Type | Filed | Value | 7d Stock | Filing |
|---|---|---|---|---|---|
| PrivateSilver Point Specialty Lending Fund | BUY | 2026-03-02 | $6.8M | — | Filing → |
| PrivateSilver Point Specialty Lending Fund | BUY |
| $81K |
| 100% |
| 2026-02-02 |
| $9.7M |
| — |
| Filing → |
| PrivateSilver Point Specialty Lending Fund | BUY | 2025-12-29 | $8.6M | — | Filing → |
| PrivateSilver Point Specialty Lending Fund | BUY | 2025-11-26 | $8.8M | — | Filing → |
| PrivateSilver Point Specialty Lending Fund | BUY | 2025-10-27 | $7.6M | — | Filing → |